Suksomboon N, Poolsup N, Boonkaew S, Suthisisang CC. Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes. J Ethnopharmacol 2011;137(3):1328-1333. View abstract.
Szilard S, Szentgyorgyi D, Demeter I. Protective effect of Legalon in workers exposed to organic solvents. Acta Med Hung 1988;45:249-56. View abstract.
Talebi A, Soltani R, Khorvash F, Jouabadi SM. The Effectiveness of Silymarin in the Prevention of Anti-tuberculosis Drug-induced Hepatotoxicity: A Randomized Controlled Clinical Trial. Int J Prev Med 2023;14:48. View abstract.
Tanamly MD, Tadros F, Labeeb S, et al. Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results. Dig Liver Dis 2004;36:752-9. View abstract.
Toomari E, Hajian S, Mojab F, Omidkhah T, Nasiri M. Evaluation of the effect of Silybum marianum ointment on episiotomy wound healing and pain intensity in primiparous women: a randomized triple blind clinical trial. BMC Complement Med Ther. 2021 Oct 7;21(1):253. View abstract.
Tóth B, Németh D, Soós A, et al. The effects of a fixed combination of Berberis aristata and Silybum marianum on dyslipidaemia - A meta-analysis and systematic review. Planta Med. 2019. View abstract.
Trinchet JC, Coste T, Levy VG. [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients]. Gastroenterol Clin Biol 1989;13:120-4. View abstract.
Valipour R, Narouie B, Momeni H, et al. Evaluation of efficacy of cholecalciferol and silymarin in improving lower urinary tract symptoms of benign prostatic hyperplasia: A double-blind, randomized, controlled trial. Urologia 2024;91(4):727-737. View abstract.
van Erp NP, Baker SD, Zhao M, et al. Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan. Clin Cancer Res 2005;11:7800-6. View abstract.
Velussi M, Cernigoi AM, De Monte A, et al. Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatol 1997;26:871-9. View abstract.
Venkataramanan R, Ramachandran V, Komoroski BJ, et al. Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures. Drug Metab Dispos 2000;28:1270-3. View abstract.
Dong W, Zhao Y, Li X, Huo J, Wang W. Corn silk polysaccharides attenuate diabetic nephropathy through restoration of the gut microbial ecosystem and metabolic homeostasis. Front Endocrinol (Lausanne) 2023;14:1232132. View abstract.
Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
George GO, Idu FK. Corn silk aqueous extracts and intraocular pressure of systemic and non-systemic hypertensive subjects. Clin Exp Optom. 2015 Mar;98(2):138-49. View abstract.
Gumaih HS, Alasbahy A, Alharethi SH, Al-Asmari SM, Al-Khulaidi AWA. Antiurolithiasis activities of Zea mays extract and its mechanism as antiurolithiasis remedy. Am J Clin Exp Urol 2023;11(5):443-451. View abstract.
Hasanudin K, Hashim P, Mustafa S. Corn silk (<em>Stigma maydis</em>) in healthcare: a phytochemical and pharmacological review. Molecules 2012;17:9697-715. View abstract.
Ikpeazu VO, Ugbogu EA, Emmanuel O, Uche-Ikonne C, Okoro B, Nnaemeka J. Evaluation of the safety of oral intake of aqueous extract of Stigma maydis (corn silk) in rats. Acta Sci Pol Technol Aliment. 2018;17(4):387-397. View abstract.
Kim YH, Cho A, Kwon SA, et al. Potential photoprotective effect of dietary corn silk extract on ultraviolet B-induced skin damage. Molecules. 2019;24(14):2587. View abstract.
Li CC, Lee YC, Lo HY, Huang YW, Hsiang CY, Ho TY. Antihypertensive effects of corn silk extract and its novel bioactive constituent in spontaneously hypertensive rats: The involvement of angiotensin-converting enzyme inhibition. Molecules. 2019;24(10):1886. View abstract.
Mohammadi A, Oroojan AA, Hashemi M, Poormoosavi SM, Dolatshahi M, Golshokouh F. Hypolipidemic and hepatoprotective effects of corn silk extract in nicotine-administered male mice. Gastroenterol Hepatol Bed Bench 2024;17(1):64-73. View abstract.
Samandarian S, Soltani R, Hajhashemi V, et al. Efficacy of an Oral Solution Containing Five Herbal Extracts in the Treatment of Urolithiasis: A Randomized, Single-blind, Placebo-controlled Clinical Trial. J Res Pharm Pract 2024;12(3):96-103. View abstract.
Shahzad MK, Amir Shahzad M, Qadeer U, Mehmood A. Investigation of phytochemical profiling and therapeutic effects of corn silk against diabetes in human male subjects. Pak J Pharm Sci 2022;35(6(Special)):1699-1703. View abstract.
Sheng L, Chen Q, Di L, Li N. Evaluation of anti-diabetic potential of corn silk in high-fat diet/streptozotocin- induced type 2 diabetes mice model. Endocr Metab Immune Disord Drug Targets. 2020. View abstract.
Shi S, Li S, Li W, Xu H. Corn silk tea for hypertension: A systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2019;2019:2915498. View abstract.
Shi S, Yu B, Li W, Shan J, Ma T. Corn silk decoction for blood lipid in patients with angina pectoris: A systematic review and meta-analysis. Phytother Res. 2019;33(11):2862-2869. View abstract.